Gemmus Pharma Company
Gemmus develops innovative pharmaceutical products for the treatment of influenza and other viral infectious diseases.
Industry:
PharmTech
Technology:
Metabolic Disorders
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Headquarters:
San Francisco, California, United States
Employee Number:
11-50
Founded Date:
2007